DV
Dividend Vision

ALEC — Alector Inc

Alector Inc (ALEC)

Total return is -89.2% over the past 7.5 years, 310.5 points behind SPY at 221.3%. Its deepest 1-year drawdown was 65.7%.

ALEC is an equity fund that tracks Alector Inc, a biotechnology company focused on neurodegenerative disease research and development. The fund holds individual company stock rather than a diversified portfolio, making it a concentrated equity investment with no current dividend distribution. This single-stock fund appeals primarily to investors seeking exposure to a specific biotech company's growth potential rather than income generation.

ALEC key facts

Asset type
Stock
Asset class
Equity
Inception date
02/07/2019
Last close
$1.96
Market cap
$166,537,776
Average volume
649021.0
Beta
0.599
Payout ratio
0.0
Forward P/E
8.4674
EPS
$-1.19